Habibizad Nazila 4
4 · Global Blood Therapeutics, Inc. · Filed Oct 4, 2022
Insider Transaction Report
Form 4
Habibizad Nazila
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-10-01+182→ 39,680 total - Exercise/Conversion
Restricted Stock Units
2022-10-01−182→ 548 total→ Common Stock (182 underlying) - Exercise/Conversion
Common Stock
2022-10-01+1,375→ 39,498 total - Gift
Common Stock
2022-09-29−3,500→ 38,123 total - Exercise/Conversion
Restricted Stock Units
2022-10-01−1,375→ 2,750 total→ Common Stock (1,375 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]The shares of Common Stock underlying the original grant of 11,000 RSUs vest in eight semi-annual installments after October 1, 2019 through October 1, 2023, subject to the Reporting Person's continuous service with the Issuer through each vesting date, and have no expiration date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F3]The shares of Common Stock underlying the original grant of 1,461 RSUs vest in eight semi-annual installments after April 1, 2020 through April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each vesting date, and have no expiration date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.